New York Life Investment Management LLC cut its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 2.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 86,490 shares of the financial services provider’s stock after selling 2,026 shares during the quarter. New York Life Investment Management LLC’s holdings in MetLife were worth $7,082,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of MET. Bank of New York Mellon Corp increased its position in shares of MetLife by 109.2% during the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock worth $722,727,000 after buying an additional 4,606,748 shares during the period. Swedbank AB increased its position in shares of MetLife by 76.0% during the fourth quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock worth $283,862,000 after buying an additional 1,496,645 shares during the period. Zurich Insurance Group Ltd FI bought a new position in MetLife during the third quarter worth $91,771,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in MetLife by 79.1% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock worth $142,378,000 after acquiring an additional 762,291 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its stake in MetLife by 256.6% during the third quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock worth $78,209,000 after acquiring an additional 682,333 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on MET. Wells Fargo & Company increased their target price on shares of MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 19th. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. JPMorgan Chase & Co. increased their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Keefe, Bruyette & Woods cut their target price on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 12th. Finally, Morgan Stanley increased their target price on shares of MetLife from $101.00 to $109.00 and gave the stock an “overweight” rating in a research note on Friday. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.58.
MetLife Stock Up 2.5 %
MetLife stock opened at $86.16 on Friday. The firm’s fifty day moving average price is $83.65 and its two-hundred day moving average price is $81.83. The firm has a market capitalization of $59.66 billion, a price-to-earnings ratio of 14.43, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 1-year low of $67.30 and a 1-year high of $89.05.
MetLife (NYSE:MET – Get Free Report) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, equities research analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be issued a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.53%. MetLife’s dividend payout ratio is currently 36.52%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- What Are Dividend Champions? How to Invest in the Champions
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 5 Best Gold ETFs for March to Curb Recession Fears
- Manufacturing Stocks Investing
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.